Enovix expects Q3 revenue of $11M; shares jump 13%
Enovix expects third-quarter revenue of $11 million, and its shares surged 13% following the announcement.
Consider a buy entry based on the REPORTING comment that the current price of $2.46 is located near the 20-day low of $2.40, testing downside support, while the 20-day high of $3.10 acts as a key resistance level upon a rebound. In addition, the upward momentum recorded in the October 27 candle with a high of $3.38 and a close of $3.35 is confirmed, supporting the entry.
Take profit when the price reaches the resistance level of $3.10, and cut losses if it drops to the support level of $2.40. This is based on the resistance and support levels suggested by REPORTING.
RSI(14) at 32.7 (oversold territory), moving averages not in a bullish alignment (potential trend weakness), volume at 0.90x the 20-day average (volume decreasing), and a -15.2% volatility rate over the past 7 days (declining price trend).
The actual return significantly outperformed the predicted return of 3.5%, reaching 36.2%. The entry decision based on news and resistance/support lines was correct, and the candle upward momentum was also accurately captured. However, it is evident that the initial target return was set too low and thus underestimated.
For the next trade, while maintaining the entry decision combining news and technical indicators, set the initial target return more aggressively, and adjust the position size if upward momentum is strong. In addition, secure profits by considering partial profit-taking when approaching resistance levels, and re-evaluate the stop-loss line if volatility increases.